Could Psychedelics Treat Personality Disorders?
Journal of Addiction Science 2022 DOI: 10.17756/jas.2022-057 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | Personality disorders Clinical psychology Psychotherapist Psychoanalysis |
| Citations | 3 |
| Key findings | Further investigation of classical psychedelics for personality disorders, including preliminary trials, is indicated despite theoretical risks and difficulties. |
Abstract
In this paper we review the existing historical literature on the use of classical psychedelics to treat personality disturbance and disorders.We address the findings and major limitations of that dataset.Finally, we ask which, if any, personality disorders are most suitable for further investigation and whether this is worthwhile.There are significant theoretical risks and difficulties but considering the clinical burden further investigation, including preliminary trials, is indicated.
Citations in the library
Cited by 2
Cites 35
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Archives of General Psychiatry September 7, 2010
- Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin Proceedings of the National Academy of Sciences January 23, 2012
and 30 more in the library